Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2013-12-12 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: RENAGE (38140), Isere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU PLAN : revenue, balance sheet and financial ratios
PHARMACIE DU PLAN is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in RENAGE (38140),
this company of category PME
shows in 2022 a net income positive of 159 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU PLAN (SIREN 799130562)
Indicator
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
158 613 €
125 576 €
105 530 €
59 656 €
84 846 €
83 257 €
90 464 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2022, PHARMACIE DU PLAN generates positive net income of 159 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2022: 90 k€ -> 159 k€.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
158 613 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 31%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
31.323%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
65.393%
Asset age ratio (2022)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
Debt ratio
219.727
156.847
117.232
99.119
69.461
48.508
31.323
Financial autonomy
27.837
35.271
42.195
46.095
52.397
57.862
65.393
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
31.322022
2020
2021
2022
Q1: 24.52
Med: 74.72
Q3: 182.51
Good-11 pts over 3 years
In 2022, the debt ratio of PHARMACIE DU PLAN (31.32) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
65.39%2022
2020
2021
2022
Q1: 28.54%
Med: 47.06%
Q3: 66.61%
Good+10 pts over 3 years
In 2022, the financial autonomy of PHARMACIE DU PLAN (65.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 221.66. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
221.656
Liquidity indicators evolution PHARMACIE DU PLAN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
Liquidity ratio
203.2
231.19
251.933
232.375
211.397
205.205
221.656
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
221.662022
2020
2021
2022
Q1: 145.17
Med: 199.48
Q3: 274.99
Good
In 2022, the liquidity ratio of PHARMACIE DU PLAN (221.66) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DU PLAN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of PHARMACIE DU PLAN is estimated at
1 866 321 €
(range 1 254 538€ - 2 799 135€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
1254k€1866k€2799k€
1 866 321 €Range: 1 254 538€ - 2 799 135€
NAF 5 année 2022
Valuation method used
Net Income Multiple
158 613 €
×
11.8x
=1 866 321 €
Range: 1 254 539€ - 2 799 135€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU PLAN with other companies in the same sector:
Frequently asked questions about PHARMACIE DU PLAN
What is the revenue of PHARMACIE DU PLAN ?
The revenue of PHARMACIE DU PLAN is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DU PLAN profitable?
Yes, PHARMACIE DU PLAN generated a net profit of 159 k€ in 2022.
Where is the headquarters of PHARMACIE DU PLAN ?
The headquarters of PHARMACIE DU PLAN is located in RENAGE (38140), in the department Isere.
Where to find the tax return of PHARMACIE DU PLAN ?
The tax return of PHARMACIE DU PLAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU PLAN operate?
PHARMACIE DU PLAN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart